PEVIANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.636
AS - Asia 1.080
EU - Europa 879
SA - Sud America 123
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.758
Nazione #
US - Stati Uniti d'America 1.592
CN - Cina 482
SG - Singapore 263
IE - Irlanda 189
IT - Italia 158
HK - Hong Kong 134
RU - Federazione Russa 117
BR - Brasile 90
DE - Germania 85
VN - Vietnam 85
FI - Finlandia 76
UA - Ucraina 63
FR - Francia 49
GB - Regno Unito 40
IN - India 32
SE - Svezia 30
CA - Canada 25
ZA - Sudafrica 20
BE - Belgio 18
BD - Bangladesh 15
MX - Messico 14
AR - Argentina 12
PL - Polonia 12
ES - Italia 11
ID - Indonesia 9
JP - Giappone 9
IQ - Iraq 8
NL - Olanda 8
LT - Lituania 6
TR - Turchia 6
VE - Venezuela 6
CO - Colombia 5
PH - Filippine 5
AT - Austria 4
KE - Kenya 4
PK - Pakistan 4
UZ - Uzbekistan 4
DK - Danimarca 3
EG - Egitto 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
PE - Perù 3
SA - Arabia Saudita 3
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
MY - Malesia 2
PT - Portogallo 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.758
Città #
Dallas 218
Dublin 189
Chandler 175
San Jose 162
Singapore 145
Ashburn 138
Hong Kong 133
Beijing 110
Nanjing 100
Jacksonville 81
Ann Arbor 54
Pavia 54
Boardman 53
Los Angeles 38
Lauterbourg 37
Princeton 35
Lawrence 34
Helsinki 31
Wilmington 31
New York 30
Nanchang 29
Munich 27
Council Bluffs 24
Ho Chi Minh City 23
Medford 23
Milan 23
Moscow 23
Redondo Beach 21
Hanoi 20
Piscataway 19
Shanghai 19
Buffalo 18
Hebei 18
Johannesburg 16
São Paulo 16
Changsha 15
Jiaxing 15
Brussels 14
Orem 13
Shenyang 13
Tianjin 13
The Dalles 12
Warsaw 12
Chicago 11
Mexico City 10
Chennai 9
Manchester 9
Santa Clara 9
Seattle 9
Toronto 9
Woodbridge 9
Denver 8
Montreal 8
Tokyo 8
Turku 8
New Delhi 7
Rome 7
Stockholm 7
Atlanta 6
Chongqing 6
Da Nang 6
Falls Church 6
Frankfurt am Main 6
Hangzhou 6
Washington 6
Columbus 5
Mumbai 5
Naples 5
Nuremberg 5
Des Moines 4
Haiphong 4
Houston 4
Jinan 4
London 4
Phoenix 4
Piemonte 4
Pune 4
Tappahannock 4
Tashkent 4
Thái Nguyên 4
Amsterdam 3
Ankara 3
Boston 3
Caracas 3
Curitiba 3
Dhaka 3
Erbil 3
Fairfield 3
Guangzhou 3
Lima 3
Nairobi 3
Newark 3
Paris 3
Poplar 3
Qingdao 3
Rio de Janeiro 3
Secaucus 3
Apucarana 2
Auburn Hills 2
Baghdad 2
Totale 2.565
Nome #
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 162
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 147
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 146
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 144
Essential Amino Acid Supplementation May Attenuate Systemic Inflammation and Improve Hypoalbuminemia in Subacute Hemiplegic Stroke Patients 142
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 139
Identification of a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. 126
Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. 117
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 117
COMPOSITIONS AND METHODS FOR TARGETING CELLS 112
In Situ Agar – Carbomer Hydrogel Polycondensation:a Chemical Approach to Regenerative Medicine 111
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 109
COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM 107
Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis 106
Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase. 96
Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading 94
Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: A challenge or an opportunity? 94
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain 92
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 89
Use of arylalkanolamines as sigma-1 receptor antagonists 87
Fast deep learning reconstruction techniques for preclinical magnetic resonance fingerprinting 84
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 82
Studies on the enantiomers of RC-33, promising neuroprotective agents acting as sigma1 receptor agonists. Isolation, configurational assignment and biological profile 81
Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. 78
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System 78
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 77
Neurophysiological characterisation of the g93a ALS rat model 77
Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice. 76
Sigma1 Receptor Agonists in motor dysfunction pathologies treatment – a medicinal chemistry perspective 71
Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients 70
Effect of Lipid Nanoparticle Physico-Chemical Properties and Composition on Their Interaction with the Immune System 67
Synthesis and characterization of a “clickable” pbr28 tspo-selective ligand derivative suitable for the functionalization of biodegradable polymer nanoparticles 65
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells 64
Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer's disease mouse model 63
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release 63
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 59
Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. 57
Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma 57
An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model 55
Metallothioneins are neuroprotective agents in lysosomal storage disorders 53
T1-weighted dynamic contrast-enhanced MRI is a noninvasive marker of epidermal growth factor receptor VIII status in cancer stem cell-derived experimental glioblastomas 52
Simultaneous flow cytometric characterization of multiple cell types retrieved from mouse brain/spinal cord through different homogenization methods 45
null 9
Increased CSF levels of soluble AXL at diagnosis correlate with poor prognosis in patients affected by amyotrophic lateral sclerosis 1
Improving mitochondria-associated endoplasmic reticulum membranes integrity as converging therapeutic strategy for rare neurodegenerative diseases and cancer 1
Totale 3.822
Categoria #
all - tutte 15.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022173 7 2 8 3 5 7 7 15 16 6 18 79
2022/2023529 56 54 1 33 43 58 0 29 231 2 12 10
2023/2024230 27 30 7 10 22 59 5 18 2 10 36 4
2024/2025651 20 44 13 18 23 72 35 34 159 26 68 139
2025/20261.604 112 78 283 171 182 70 272 65 147 117 61 46
Totale 3.822